{
  "Disease": [
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Disease\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: While nocistatin ( 0 . 5 - 5 . 0 nmol mouse - 1 , i . c . v . ) administered 30 min before spontaneous alternation performance or the training session of the passive avoidance task , had no effect on spontaneous alternation or passive avoidance behaviours , a lower per cent alternation and shorter median step - down latency in the retention test were obtained in nociceptin ( 1 . 5 and / or 5 . 0 nmol mouse - 1 , i . c . v . ) - treated normal mice .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| None identified in the paragraph |\n\nThe paragraph is about the effects of nocistatin and nociceptin on mouse behavior in a spontaneous alternation and passive avoidance task. It mentions the administration of these compounds and the resulting behaviors, but it does not mention any specific diseases or health conditions."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Disease\" and present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| None identified in the paragraph |\n\nThe paragraph describes the effects of nocistatin and nociceptin on mouse behavior in a spontaneous alternation and passive avoidance task. It mentions the administration of these compounds and the resulting behaviors, but it does not mention any specific diseases or health conditions. Therefore, there are no entities in the paragraph that clearly refer to diseases."}
  ],
  "Chemical": [
    {"role": "user", "content": "Please identify the \"Chemical\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Chemical\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: While nocistatin ( 0 . 5 - 5 . 0 nmol mouse - 1 , i . c . v . ) administered 30 min before spontaneous alternation performance or the training session of the passive avoidance task , had no effect on spontaneous alternation or passive avoidance behaviours , a lower per cent alternation and shorter median step - down latency in the retention test were obtained in nociceptin ( 1 . 5 and / or 5 . 0 nmol mouse - 1 , i . c . v . ) - treated normal mice .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| nocistatin (0.5-5 nmol mouse-1, i.c.v.) |\n| nociceptin (1.5 and/or 5 nmol mouse-1, i.c.v.) |"},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Chemical\" and present the valid entities as a Markdown table with one column \"Chemical\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| nocistatin (0.5-5 nmol in mouse-1, i.c.v.) |\n| nociceptin (1.5 and/or 5 nmol in mouse-1, i.c.v.) |\n\nNote: i.c.v. stands for intracerebroventricular."}
  ]
}